Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO
SGO 2022 on a Randomized Phase 3 Trial of IP vs. IV Carboplatin With Dose-Dense Weekly Paclitaxel in Ovarian/Fallopian Tube/Primary Peritoneal Carcinoma
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Keiichi Fujiwara
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Keiichi Fujiwara
Login to view comments.
Click here to Login
